Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
- PMID: 32251522
- DOI: 10.1111/biom.13246
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan
Comment in
-
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):602-605. doi: 10.1111/biom.13245. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251524 No abstract available.
Comment on
-
Predictively consistent prior effective sample sizes.Biometrics. 2020 Jun;76(2):578-587. doi: 10.1111/biom.13252. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32142163
References
REFERENCES
-
- FDA (2019) Draft Guidance for Industry: Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products. https://www.fda.gov/regulatory-information/search-fda-guidance-documents.... Accessed September 23, 2019.
-
- FDA (2018) Framework for FDA's real-world evidence program. https://www.fda.gov/media/120060/download. Accessed December 2018.
-
- Lee, S.M. and Cheung, Y. K. (2009) Model calibration in the continual reassessment method. Clinical Trials, 6(3), 227-238.
-
- Morita, S., Thall, P.F. and Müller, P. (2008) Determining the effective sample size of a parametric prior. Biometrics, 64(2), 595-602.
-
- Neuenschwander, B., Weber, S., Schmidli, H. and O'Hagan, A. (2020) Predictively consistent prior effective sample size. Biometrics, https://doi.org/10.1111/biom.13252.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
